SCHEMBL7216152

SCHEMBL7216152

Cn1ccc(NC(=O)c2c[nH]c3c2-c2ncccc2CCC3)n1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 0.42
PDE4D Q08499 2/20 0.42
CHRM1 P11229 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM3 P20309 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
GRM5 P41594 3/20 0.40
GCK P35557 1/20 0.39
SYK P43405 1/20 0.38
BUB1 O43683 1/20 0.37
MAPK7 Q13164 1/20 0.36
RPS6KA3 P51812 1/20 0.35
RPS6KA2 Q15349 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7223214 0.87 NPSR1 (0.34) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL7222958 0.87 NPSR1 (0.34) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL7222707 0.86 GCK (0.34) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL7217066 0.85 GCK (0.40) CHRM1CHRM2CHRM4CHRM3GCK
SCHEMBL7218419 0.85 GCK (0.40) CHRM1CHRM2CHRM4CHRM3GCK
SCHEMBL7218337 0.84 GCK (0.33) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL7218258 0.84 GCK (0.33) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL7218239 0.84 GCK (0.33) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL7223026 0.84 GCK (0.33) PDE4BPDE4DCHRM1CHRM2CHRM4
SCHEMBL6309724 0.84 MEN1 (0.44) NPC1RAB9AGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653471-B2 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction NEUROGEN CORPORATION 2003-11-25 US disclosed